Bayer Aspirin: Manufacturer Sued For Marketing Drugs Without FDA Approval

Pharmaceutical giant, Bayer Corporation, has been sued for marketing Bayer Aspirin with Heart Advantage and Bayer Women’s Low-Dose Aspirin Plus Calcium without approval from the U.S. Food & Drug Administration (FDA). Eight separate product liability class action lawsuits have been filed against Bayer over these practices and have now been consolidated into Multidistrict Litigation (MDL) in New York.

→ Read More